# Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease

> **NCT03130517** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Haemolysis Neonatal

## Interventions

- **DRUG:** intravenous immunoglobulin

## Key facts

- **NCT ID:** NCT03130517
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130517, "Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03130517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*